Biotech, pharmaceutical, and biologics companies are in desperate need of a good and trusted CRO that can help them achieve projected goals within given timelines; to fill for the technology and knowledge gaps that in-house teams do not possess. For instance, in pharmacovigilance, new safety risks are constantly emerging, as are new means of locating and identifying them. Pharmacovigilance specialists also require experience and the ability to understand whether a safety signal is significant. This is where Marti Farm comes into the picture with ten years of proven track record in providing multiple small, midsize, and large pharma companies with end-to-end management and set up pertaining to pharmacovigilance processes.
A fast-growing ISO 9001:2015 certified CRO, the company has all the required expertise for providing successful, efficient and impeccable support to meet the individual needs of clients and partners worldwide. “We are always thriving to find new ways to ensure utmost success for our clients and partners, as well as to ensure continuous education and training for our employees in all fields and areas we work,” says Dr. Martina Diminić Smetiško, the managing director at Marti Farm. As such, while Croatia, and the rest of the world, has been going through a difficult time caused by the sudden spread of the coronavirus (COVID-19), Marti Farm has been prepared and trained to operate as usual even in the pandemic situation.
Marti Farm is highly valued as an expert by its clients and partners on the East Adriatic Region and other EU and non-EU markets. Based on its global network of providers, Marti Farm performs highest-quality services on the market, while ensuring that customers’ business needs are fulfilled quickly and efficiently. “We go to great lengths to ensure that our scope of services is reliable, transparent, and compliant with industry regulations worldwide,” mentions Dr. Martina. At its core, Marti Farm delivers a multi-client, web-based safety database and pharmacovigilance solution, Sympto®
Designed in particular to minimize risks and facilitate the detection of potential signals, Sympto® solution is an excellent tool for both elementary and advanced pharmacovigilance tasks. Marti Farm’s PV team has processed over 600,000 literature searches and detected more than 100000 ICSR’s for over 70 clients worldwide through Sympto. Sympto® solution is capable of enabling contract research organizations, pharmaceuticals, and biotech companies to achieve better compliance, faster reporting of cases, and more efficient literature screening. “We have our innovative module Activity Reports within Sympto that can easily be exported to PDF. It incorporates the entire pharmacovigilance data for certain periods and downloaded, which makes it great for audits, inspections and reconciliation processes,” states Dr. Martina.
Marti Farm’s business model is designed to help clients to stay within their budget.
“We always tend to give the best possible estimate of the price on a monthly and annual basis, which helps them predict how much it would cost,” says Dr. Martina. In an instance, the company helped a small pharma company in establishing the entire pharmacovigilance system from scratch as they didn’t know even where to start. Marti Farm’s team of experts enabled them with SOPs, WIs, and pharmacovigilance training and ensured the safety of their medicinal products. The client was also provided with affordable pricing, which helped them in staying within the budgets. Since then, Marti Farm has been responsible for managing this client on a global level and local pharmacovigilance persons in the respective regions as well.
We go to great lengths to ensure that our scope of services is reliable, transparent, and compliant with industry regulations worldwide
In another case, Marti Farm helped a big pharma client in the process of German inspection of their GVP system. The company has been assisting the client in local literature searches in several EU and non-EU countries for around 40 medicinal products for several years. During their inspection, one of their QPPVs reached out to Marti Farm, looking for a way to send all the literature findings for the first six months of 2019 in one document. The client needed it quickly, as well. Through Sympto®, Marti Farm managed to download a 600-page pdf document within minutes. It contained all of the literature searches for the given period. The client said that it was the quickest and most composed report they have ever seen, and as a result, the inspection was conducted successfully.
The examples stand as a testament to the huge role that Marti Farm’s team plays in delivering results. “Our team has 30+ highly educated experts from different areas of specialty that have over 200 years combined of pharma industry experience,” informs Dr. Martina. “We are supporting our clients in navigating and implementing the industry’s most rigorous documentation and regulatory requirements while our experts aim to keep them up-to-date on the latest regulatory developments.” What makes this possible is the Marti Farm’s team of experts, with 10 to 20 years of experience in pharmacovigilance with MD, DMD, MPharm background. Martina further mentions that every Tuesday, the team has a small breakfast meeting at 9 AM, usually where each department contributes with coffee, donuts, or some other pastries. “We hang out and try to thrive towards even better connection as well as a more positive work environment,” she adds.
Through its industry know-how and a compassionate team, Marti Farm has truly carved a unique niche, and going forward, the company will continue to grow geographically as well as with the depth and breadth of services. “Each day, we are working on raising our quality and performance to a higher level. Currently, we have several different projects in plan for 2020 and 2021. Additionally, we introduced at the beginning of this year, our new services which are GMP/GLP/GCP auditing and consulting to help our clients from the drug discovery, formulation, and all the way towards the approval,” concludes Dr. Martina.